DAXOR CORP (DXR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2011, filed Mar 28, 2012. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DXR SEC filings page.
DAXOR CORP (DXR) reported $1.4M in revenue for fiscal year 2011, down 8.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Daxor's dominant mechanic is development spending funded ahead of commercial scale, leaving operating cash flow persistently negative.
By FY2011, R&D spending reached$2.7M against revenue of$1.4M , while operating cash flow remained negative. That combination indicates a business whose reported activity is still centered on funding development rather than generating self-financing commercial receipts.
Cash conversion weakened earnings quality: FY2010 net income was
Gross margin held broadly steady, moving from
Financial Health Signals
DAXOR CORP does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
DAXOR CORP scores 1.38, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($60.0M) relative to total liabilities ($49.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
DAXOR CORP passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
DAXOR CORP reported a net loss of $7.2M while operations used $6.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2011.
Cash & Balance Sheet
DAXOR CORP recorded an outflow of $995K in free cash flow in Q4 2011, representing a cash shortfall after capex. This represents an increase of 46.8% from the same quarter a year earlier. Against the prior quarter it is down 48.1%.
DAXOR CORP held $60K in cash as of Q4 2011; long-term debt is not reported for that period.
DAXOR CORP paid $0.10 per share in dividends in Q4 2011. This represents a decrease of 84.6% from the same quarter a year earlier.
Margins & Returns
None of these metrics is reported for Q4 2011.
Capital Allocation
DAXOR CORP spent $230K on share buybacks in Q4 2011, returning capital to shareholders by reducing shares outstanding. This represents an increase of 3617.8% from the same quarter a year earlier. Against the prior quarter it is up 214974.8%.
DAXOR CORP invested $5K in capex in Q4 2011, funding long-term assets and infrastructure. This represents a decrease of 86.6% from the same quarter a year earlier. Against the prior quarter it is down 91.9%.
Not reported for Q4 2011.
DXR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'1110-K | Q3'1110-Q | Q2'1110-Q | Q4'1010-K | Q3'1010-Q | Q2'1010-Q |
|---|---|---|---|---|---|---|
| Revenue | N/A | $341K-24.8% | $358K-2.8% | N/A | $453K | $368K |
| Cost of Revenue | N/A | $149K-19.6% | $161K-2.8% | N/A | $186K | $165K |
| Gross Profit | N/A | $192K-28.4% | $197K-2.7% | N/A | $268K | $203K |
| R&D Expenses | N/A | $637K-8.3% | $670K-8.8% | N/A | $695K | $735K |
| SG&A Expenses | N/A | $816K-4.9% | $871K-10.5% | N/A | $858K | $973K |
| Operating Income | N/A | -$1.3M+1.9% | -$1.3M+10.7% | N/A | -$1.3M | -$1.5M |
| EBITDA | N/A | -$1.2M+1.8% | N/A | N/A | -$1.2M | N/A |
| Interest Expense | N/A | $30K+46.5% | $81K+811.1% | N/A | $20K | $9K |
| Income Tax | N/A | -$2.8M-258.1% | -$182K-356.4% | N/A | $1.8M | -$40K |
| Net Income | N/A | -$4.2M-260.6% | -$185K-198.0% | N/A | $2.6M | $188K |
Not reported in any period shown, so not listed: EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
DXR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'1110-K | Q3'1110-Q | Q2'1110-Q | Q4'1010-K | Q3'1010-Q | Q2'1010-Q |
|---|---|---|---|---|---|---|
| Total Assets | $85.7M-6.0% | $88.3M | $96.2M | $91.2M | N/A | N/A |
| Current Assets | $81.7M-6.1% | $84.1M | $92.1M | $87.0M | N/A | N/A |
| Cash & Equivalents | $60K+3.3% | $30K-72.2% | $112K-47.6% | $58K | $107K | $213K |
| Short-Term Investments | $55.8M+3.6% | $52.3M | $54.1M | $53.9M | $0 | $0 |
| Inventory | $302K-17.1% | $313K | $357K | $364K | N/A | N/A |
| Accounts Receivable | $220K+22.9% | $190K | $193K | $179K | N/A | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $49.5M+12.0% | $50.6M | $50.7M | $44.2M | N/A | N/A |
| Current Liabilities | $49.3M+12.2% | $50.4M | $50.4M | $43.9M | N/A | N/A |
| Non-Current Liabilities | $244K-18.7% | $259K | $273K | $300K | N/A | N/A |
| Total Equity | $36.2M-22.9% | $37.6M | $45.6M | $47.0M | N/A | N/A |
| Retained Earnings | $24.7M-25.0% | $26.7M | $30.8M | $33.0M | N/A | N/A |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
DXR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'1110-K | Q3'1110-Q | Q2'1110-Q | Q4'1010-K | Q3'1010-Q | Q2'1010-Q |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -$990K+46.1% | -$613K+49.8% | N/A | -$1.8M | -$1.2M | N/A |
| Depreciation & Amortization | $71K-3.4% | $72K-2.0% | N/A | $74K | $74K | N/A |
| Capital Expenditures | $5K-86.6% | $58K-35.8% | N/A | $35K | $91K | N/A |
| Free Cash Flow | -$995K+46.8% | -$671K+48.9% | N/A | -$1.9M | -$1.3M | N/A |
| Investing Cash Flow | -$8.1M-224.8% | -$3.3M-2907.5% | N/A | $6.5M | -$109K | N/A |
| Financing Cash Flow | $9.1M+294.5% | $3.8M+210.8% | N/A | -$4.7M | $1.2M | N/A |
| Dividends Paid | $421K-84.7% | $0-100.0% | N/A | $2.7M | $1.1M | N/A |
| Share Buybacks | $230K+3617.8% | $107-99.9% | N/A | $6K | $126K | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation.
DXR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'1110-K | Q3'1110-Q | Q2'1110-Q | Q4'1010-K | Q3'1010-Q | Q2'1010-Q |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | 56.2%-2.8pp | 55.1%0.0pp | N/A | 59.0% | 55.1% |
| Operating Margin | N/A | -369.9% | -375.2% | N/A | -283.5% | -408.6% |
| Net Margin | N/A | -1227.2% | -51.5%-102.7pp | N/A | 574.7% | 51.1% |
| Return on Equity | N/A | -11.1% | -0.4% | N/A | N/A | N/A |
| Return on Assets | N/A | -4.7% | -0.2% | N/A | N/A | N/A |
| Current Ratio | 1.66-0.3x | 1.67 | 1.83 | 1.98 | N/A | N/A |
| Debt-to-Equity | 1.37+0.4x | 1.35 | 1.11 | 0.94 | N/A | N/A |
| Asset Turnover | N/A | 0.00 | 0.00 | N/A | N/A | N/A |
| FCF Margin | N/A | -197.0% | N/A | N/A | -289.7% | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| DAXOR CORP DXR | FY2011 | $1.4M | -$7.2M | N/A | $60.0M | — |
| Jin Medical ZJYL | FY2025 | $20.7M | $1.2M | 5.8% | $153.2M | 46/100 |
| Pro-Dex Inc Colo PDEX | FY2026 | $77.5M | $13.7M | 17.6% | $235.2M | 72/100 |
| Milestone Scient MLSS | FY2025 | $9.0M | $5.7M | 63.8% | $41.6M | 27/100 |
Where DAXOR CORP Ranks
Frequently Asked Questions
What is DAXOR CORP's annual revenue?
DAXOR CORP (DXR) reported $1.4M in total revenue for fiscal year 2011. This represents a -8.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is DAXOR CORP's revenue growing?
DAXOR CORP (DXR) revenue declined by 8.4% year-over-year, from $1.6M to $1.4M in fiscal year 2011.
Is DAXOR CORP profitable?
No, DAXOR CORP (DXR) reported a net income of -$7.2M in fiscal year 2011.
What is DAXOR CORP's EBITDA?
DAXOR CORP (DXR) had EBITDA of -$5.5M in fiscal year 2011, measuring earnings before interest, taxes, depreciation, and amortization.
What is DAXOR CORP's gross margin?
DAXOR CORP (DXR) had a gross margin of 54.9% in fiscal year 2011, indicating the percentage of revenue retained after direct costs of goods sold.
Does DAXOR CORP pay dividends?
Yes, DAXOR CORP (DXR) paid $0.25 per share in dividends during fiscal year 2011.
What is DAXOR CORP's return on equity (ROE)?
DAXOR CORP (DXR) has a return on equity of -19.8% for fiscal year 2011, measuring how efficiently the company generates profit from shareholder equity.
What is DAXOR CORP's free cash flow?
DAXOR CORP (DXR) recorded an outflow of $6.6M in free cash flow during fiscal year 2011. This represents a -10.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is DAXOR CORP's operating cash flow?
DAXOR CORP (DXR) recorded an outflow of $6.5M in operating cash flow during fiscal year 2011, representing cash used by core business activities.
What are DAXOR CORP's total assets?
DAXOR CORP (DXR) had $85.7M in total assets as of fiscal year 2011, including both current and long-term assets.
What are DAXOR CORP's capital expenditures?
DAXOR CORP (DXR) invested $123K in capital expenditures during fiscal year 2011, funding long-term assets and infrastructure.
How much does DAXOR CORP spend on research and development?
DAXOR CORP (DXR) invested $2.7M in research and development during fiscal year 2011.
What is DAXOR CORP's current ratio?
DAXOR CORP (DXR) had a current ratio of 1.66 as of fiscal year 2011, which is generally considered healthy.
What is DAXOR CORP's debt-to-equity ratio?
DAXOR CORP (DXR) had a debt-to-equity ratio of 1.37 as of fiscal year 2011, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is DAXOR CORP's return on assets (ROA)?
DAXOR CORP (DXR) had a return on assets of -8.4% for fiscal year 2011, measuring how efficiently the company uses its assets to generate profit.
What is DAXOR CORP's P/E ratio?
DAXOR CORP (DXR) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2011). The market capitalization is $60.0M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is DAXOR CORP's price-to-sales ratio?
DAXOR CORP (DXR) trades at 41.5x sales, its market capitalization divided by revenue of $1.4M revenue, FY2011. The market capitalization is $60.0M as of Sep 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does DAXOR CORP's liquidity compare with its operating cash outflow?
At the end of fiscal year 2011, DAXOR CORP (DXR) held $55.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $6.5M over that year. Dividing the one by the other, the reported balance equals about 103 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is DAXOR CORP's Altman Z-Score?
DAXOR CORP (DXR) has an Altman Z-Score of 1.38, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is DAXOR CORP's Piotroski F-Score?
DAXOR CORP (DXR) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are DAXOR CORP's earnings high quality?
DAXOR CORP (DXR) reported a net loss of $7.2M while operations used $6.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.